During the past decade, Sabal Eye Care conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sabal Eye Care" are "Visual Acuity" (13 trials), "Juvenile Myopia" (4 trials), "Myopia" (3 trials), "Blepharoptosis" (2 trials) and "Ocular Physiology" (2 trials). Many other conditions were trialed in "Sabal Eye Care" in a lesser frequency.

Most popular intervention types in "Sabal Eye Care" are "Device" (23 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Novel spectacle lens design" (3 trials), "Spectacle lenses" (3 trials), "RVL-1201" (2 trials), "Vehicle ophthalmic solution" (2 trials) and "comfilcon A" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sabal Eye Care" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Sabal Eye Care". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Sabal Eye Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sabal Eye Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 23 trials that are defined as “Not Applicable".